Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patientsRobin Foà, Anna Guarini, Ilaria Del Giudice et al.|American Journal of Hematology|2014Cited by 114
Safety and efficacy of bortezomib‐based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMAFortunato Morabito, Michèle Cavo, Massimo Gentile et al.|European Journal Of Haematology|2009Cited by 81
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experienceLuca Laurenti, Robin Foà, Michela Tarnani et al.|American Journal of Hematology|2011Cited by 53
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM studyAntonio Cuneo, Paolo Ghia, George Follows et al.|Haematologica|2018Cited by 35
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departmentsLuca Laurenti, Giovanni D’Arena, Idanna Innocenti et al.|Leukemia Research|2015Cited by 31